Within the first few years of initiating injection drug use, over half of people who inject drugs (PWID) will become infected with hepatitis C virus (HCV). Preventing hepatitis transmission among PWID will require a comprehensive approach to harm reduction services including increased access to syringe services programs (SSPs), Medication Assisted Treatment (MAT), screening and diagnosis […]

Go to Original Post